论文部分内容阅读
我院在常规治疗的基础上采用新型降压药巯甲丙脯酸(Captopril)简称(CPT)治疗小儿顽固性心衰24例取得较好效果简要报道如下。临床资料男16例、女8例;年龄分布3～28天4例,1～6月7例,7～12月8例,1～3岁2例,3岁以上3例。原发病因先心4例(室缺2例、法乐氏四联症1例、动脉导管未闭1例),喘息性肺炎12例、败血症休克2例、风湿性全心炎1
Our hospital in the conventional treatment based on the use of a new type of antihypertensive drugs captopril (Captopril) referred to (CPT) treatment of refractory infants with 24 cases of good results obtained are briefly reported as follows. Clinical data of 16 males and 8 females; age distribution of 3 to 28 days in 4 cases, 1 to 6 months in 7 cases, 7 to December in 8 cases, 1 to 3 years old in 2 cases, 3 years old and 3 cases. Primary etiology in 4 cases (2 cases of ventricular septal defect, tetralogy of Fallot in 1 case, patent ductus arteriosus in 1 case), asthmatic pneumonia in 12 cases, septic shock in 2 cases, rheumatoid pneumonia in 1